RxDoctor Payments Data

Amanda Troup, APRN

Family · Ocala, FLNPI 1740991033

Payments from drug & device makers

$782in general payments, 2019–2025

Across 33 payments — averaging $23.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$184
  • AbbVie$177
  • Amgen$139
  • GSK$57
  • Exact Sciences$53
  • Idorsia Pharmaceuticals US Inc$47
  • plus $125 from 5 others

What the payments were for

  • Food & beverage$782100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$782 in reported general payments places this provider in the 65th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$34,948
Medicare patients
148
Services billed
387

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide19$23,707
PaxlovidNirmatrelvir/Ritonavir15$2,808
Cephalexin20$600
Prednisone119$573
Alprazolam56$495
Tramadol Hcl58$488
Omeprazole16$383
Albuterol Sulfate HfaAlbuterol Sulfate22$368
Gabapentin20$344
Doxycycline Hyclate46$328
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$262
Clonazepam22$229
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav37$219
Levothyroxine Sodium32$217
Zolpidem Tartrate34$209

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$17$23,70719 claims
PfizerPaxlovid$20$2,80815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 14,618 family providers in Florida.

Other family in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →